New York, NY - January 28, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a preclinical-stage pharmaceutical company focused in …
New York, NY - January 28, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a preclinical-stage pharmaceutical company focused in …